X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7834) 7834
Publication (1147) 1147
Book Review (40) 40
Book Chapter (31) 31
Dissertation (15) 15
Newsletter (10) 10
Conference Proceeding (6) 6
Magazine Article (6) 6
Web Resource (3) 3
Journal / eJournal (2) 2
Book / eBook (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4648) 4648
index medicus (4317) 4317
serogroup (3780) 3780
animals (2225) 2225
microbiology (2211) 2211
infectious diseases (2070) 2070
immunology (1961) 1961
female (1871) 1871
male (1694) 1694
vaccines (1236) 1236
epidemiology (1184) 1184
infant (1175) 1175
adult (1157) 1157
child (1136) 1136
adolescent (1117) 1117
child, preschool (1112) 1112
disease (1035) 1035
meningitis (994) 994
neisseria meningitidis (967) 967
vaccination (872) 872
research (820) 820
analysis (804) 804
serotyping (795) 795
neisseria-meningitidis (763) 763
identification (742) 742
middle aged (742) 742
prevalence (741) 741
children (736) 736
meningococcal vaccines - immunology (729) 729
strains (701) 701
young adult (688) 688
virulence (673) 673
immunization (648) 648
bacteria (644) 644
phylogeny (630) 630
health aspects (627) 627
veterinary sciences (626) 626
serogroups (618) 618
medicine, research & experimental (615) 615
genotype (611) 611
infections (605) 605
mice (579) 579
infection (573) 573
aged (568) 568
meningococcal infections - prevention & control (565) 565
medicine (558) 558
vaccine (551) 551
antigens (550) 550
serotypes (545) 545
biotechnology & applied microbiology (542) 542
immunogenicity (542) 542
meningococcal disease (542) 542
antibodies, bacterial - blood (530) 530
proteins (519) 519
research article (508) 508
meningococcal infections - epidemiology (504) 504
molecular sequence data (501) 501
meningococcal vaccines - administration & dosage (485) 485
polymerase chain reaction (484) 484
united-states (480) 480
meningococcal infections - microbiology (466) 466
cattle (450) 450
surveillance (450) 450
public health (445) 445
disease outbreaks (444) 444
antibodies (442) 442
outbreak (435) 435
salmonella (430) 430
conjugate vaccine (425) 425
virology (422) 422
incidence (418) 418
infant, newborn (412) 412
genetic aspects (404) 404
epidemics (403) 403
escherichia coli (399) 399
neisseria meningitidis, serogroup b - immunology (399) 399
neisseria meningitidis - genetics (395) 395
neisseria meningitidis - immunology (389) 389
anti-bacterial agents - pharmacology (381) 381
sequence analysis, dna (381) 381
microbial sensitivity tests (380) 380
meningitis, meningococcal - epidemiology (379) 379
bacterial proteins - genetics (377) 377
meningitis, meningococcal - prevention & control (369) 369
allergy and immunology (367) 367
streptococcus pneumoniae (360) 360
genes (358) 358
risk factors (358) 358
pneumonia (356) 356
serogroup-b (356) 356
streptococcus pneumoniae - classification (351) 351
public, environmental & occupational health (350) 350
viruses (348) 348
carriage (347) 347
antigens, bacterial - immunology (345) 345
multidisciplinary sciences (345) 345
neisseria meningitidis - classification (334) 334
pediatrics (326) 326
molecular epidemiology (322) 322
vaccines, conjugate - immunology (321) 321
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7376) 7376
French (152) 152
Spanish (98) 98
Japanese (91) 91
Russian (61) 61
Chinese (51) 51
German (42) 42
Portuguese (20) 20
Polish (13) 13
Czech (8) 8
Korean (8) 8
Hungarian (7) 7
Turkish (7) 7
Italian (6) 6
Dutch (5) 5
Norwegian (4) 4
Danish (3) 3
Persian (2) 2
Romanian (2) 2
Catalan (1) 1
Greek (1) 1
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1995, ISBN 0471952591, viii, 316 p., [4] p. of col. plates
Book
Journal of Infection, ISSN 0163-4453, 2015, Volume 71, Issue 5, pp. 544 - 552
Summary Objectives Neisseria meningitidis is a leading cause of meningitis and septicaemia. The hyperinvasive ST-11 clonal complex (cc11) caused serogroup C... 
Infectious Disease | Meningococcal | Serogroup C | Genome | ST-11 clonal complex | Serogroup W | INFECTIOUS DISEASES | CLONAL COMPLEX | NEISSERIA-MENINGITIDIS | VACCINE | ET-15 CLONE | EMERGENCE | W135 | DISEASE | OUTBREAK | ET-37/ST-11 | STRAIN | Meningococcal Infections - epidemiology | Humans | Male | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Phylogeny | Multilocus Sequence Typing | Neisseria meningitidis, Serogroup B - isolation & purification | Endemic Diseases | South America - epidemiology | Homosexuality, Male | Disease Outbreaks | Neisseria meningitidis, Serogroup C - classification | Neisseria meningitidis - genetics | Neisseria meningitidis, Serogroup C - isolation & purification | Serotyping | France - epidemiology | Neisseria meningitidis, Serogroup C - genetics | South Africa - epidemiology | Serogroup | Neisseria meningitidis - isolation & purification | Neisseria meningitidis - classification | Neisseria meningitidis, Serogroup B - classification | North America - epidemiology | United Kingdom - epidemiology | Music in education | Epidemics | Respiratory tract diseases | Meningitis | Health aspects | South America | Biochemistry, Molecular Biology | Genomics | United Kingdom | Neisseria meningitidis | North America | Life Sciences | Neisseria meningitidis, Serogroup C | South Africa | Santé publique et épidémiologie | Neisseria meningitidis, Serogroup B | France | Meningococcal Infections
Journal Article
Journal of Immunology, ISSN 0022-1767, 07/2010, Volume 185, Issue 1, pp. 507 - 516
Properdin, a positive regulator of the alternative pathway (AP) of complement is important in innate immune defenses against invasive Neisserial infections.... 
C4B-BINDING PROTEIN | MOLECULAR-MECHANISM | SERUM RESISTANCE | FACTOR-H BINDING | COMPLEMENT DEFICIENCY STATES | SEROGROUP-B | HEREDITARY PROPERDIN | REGULATORY PROTEIN | FULMINANT MENINGOCOCCAL INFECTIONS | IMMUNOLOGY | CAPSULE NULL LOCUS | Neisseria meningitidis, Serogroup A - immunology | Neisseria meningitidis, Serogroup C - immunology | Humans | Neisseria meningitidis, Serogroup B - immunology | Neisseria meningitidis, Serogroup Y - genetics | Neisseria meningitidis, Serogroup B - genetics | Neisseria meningitidis, Serogroup B - metabolism | Neisseria meningitidis, Serogroup W-135 - metabolism | Neisseria meningitidis, Serogroup C - metabolism | Neisseria meningitidis, Serogroup A - metabolism | Neisseria meningitidis, Serogroup A - genetics | Neisseria gonorrhoeae - immunology | Complement Pathway, Alternative - genetics | Neisseria gonorrhoeae - genetics | Neisseria meningitidis, Serogroup C - genetics | Neisseria meningitidis, Serogroup W-135 - genetics | Bacterial Adhesion - immunology | Complement C3 - metabolism | Complement C3 Convertase, Alternative Pathway - metabolism | Properdin - physiology | Protein Binding - immunology | Neisseria meningitidis, Serogroup Y - immunology | Neisseria meningitidis, Serogroup Y - metabolism | Neisseria meningitidis, Serogroup W-135 - immunology | Complement Pathway, Alternative - immunology | Enzyme Stability - immunology | Neisseria gonorrhoeae - metabolism | Properdin - isolation & purification | Properdin - metabolism
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 10/2016, Volume 22, Issue 10, pp. 1762 - 1768
In 2015, Niger reported the largest epidemic of Neisseria meningitidis serogroup C (NmC) meningitis in sub-Saharan Africa. The NmC epidemic coincided with... 
AFRICA | INFECTIOUS DISEASES | CARRIAGE | BURKINA-FASO | W135 | MENINGOCOCCAL MENINGITIS | H BINDING-PROTEIN | DISEASE | VACCINE | SUSCEPTIBILITY | DIVERSITY | IMMUNOLOGY | Communicable Diseases, Emerging | Epidemics | Genome, Bacterial | Neisseria meningitidis, Serogroup C - genetics | Niger - epidemiology | Humans | Phylogeny | Antigens, Bacterial - genetics | Neisseria meningitidis - isolation & purification | Sequence Analysis, DNA | Meningitis, Meningococcal - epidemiology | Molecular Typing | DNA, Bacterial | Genetic Variation | Meningitis, Meningococcal - microbiology | Neisseria meningitidis - genetics | Drug Resistance, Bacterial - genetics | Neisseria meningitidis, Serogroup C - isolation & purification | Serotyping | Neisseria meningitidis/genetics | Neisseria meningitidis, Serogroup C/genetics | Life Sciences | Neisseria meningitidis/isolation & purification | Genetics | Antigens, Bacterial/genetics | Meningitis, Meningococcal/epidemiology | Meningitis, Meningococcal/microbiology | Bacteriology | Human health and pathology | Microbiology and Parasitology | Infectious diseases | Niger/epidemiology | Neisseria meningitidis, Serogroup C/isolation & purification | Drug Resistance, Bacterial/genetics | Santé publique et épidémiologie | Neisseria meningitidis serogroup C | meningitis belt | bacteria | Niger | whole-genome sequencing | Research | Serogroup C and Resurging Serogroup W, Niger, 2015 | Whole-Genome Characterization of Epidemic | Meningococcal meningitis
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 5, pp. 416 - 425
Summary Background A novel multicomponent vaccine against meningococcal capsular group B (MenB) disease contains four major components: factor-H-binding... 
Infectious Disease | ANTIBODIES | INFECTIOUS DISEASES | IMMUNOGENICITY | SEROGROUP-B VACCINE | PROTEIN | NADA | TOLERABILITY | NEISSERIA-MENINGITIDIS | SURVEILLANCE | DIVERSITY | RANDOMIZED CONTROLLED-TRIAL | Geography | Genes, Bacterial | Predictive Value of Tests | Meningococcal Vaccines - therapeutic use | Reproducibility of Results | Enzyme-Linked Immunosorbent Assay | Humans | Europe - epidemiology | Genotype | Neisseria meningitidis, Serogroup B - genetics | Adhesins, Bacterial - analysis | Antigens, Bacterial - genetics | Bacterial Typing Techniques - methods | Neisseria meningitidis, Serogroup B - isolation & purification | Meningitis, Meningococcal - epidemiology | Meningitis, Meningococcal - prevention & control | Multilocus Sequence Typing - methods | Meningitis, Meningococcal - microbiology | Neisseria meningitidis, Serogroup B - classification | DNA, Bacterial - analysis | Neisseria meningitidis, Serogroup B - pathogenicity | Population Surveillance - methods | Medical research | Glycosaminoglycans | Media coverage | Medicine, Experimental | Anticoagulants (Medicine) | Vaccines | Public health | Protein binding | Europe | Antigens, Bacterial | Meningococcal Vaccines | Adhesins, Bacterial | Multilocus Sequence Typing | DNA, Bacterial | Meningitis, Meningococcal | Life Sciences | Human health and pathology | Infectious diseases | Bacterial Typing Techniques | Santé publique et épidémiologie | Neisseria meningitidis, Serogroup B | Population Surveillance
Journal Article
Journal of Infection, ISSN 0163-4453, 2017, Volume 74, Issue 6, pp. 564 - 574
Summary Objectives This work aimed to describe the epidemiology of invasive meningococcal disease (IMD) in France, 2006–2015, including group- and... 
Infectious Disease | Invasive meningococcal disease | Neisseria meningitidis | Meningococcal C conjugate vaccination | France | Epidemiology | INFECTIOUS DISEASES | CLONAL COMPLEX | CARRIAGE | NEISSERIA-MENINGITIDIS | VACCINATION | SEROGROUP | CHILDREN | PCR-BASED IDENTIFICATION | HERD-IMMUNITY | ASSOCIATION | VACCINES | Meningococcal Infections - epidemiology | Meningococcal Infections - mortality | Humans | Middle Aged | Child, Preschool | Cost of Illness | Infant | Male | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Neisseria meningitidis, Serogroup B - isolation & purification | Incidence | Young Adult | Adult | Female | Neisseria meningitidis - genetics | Neisseria meningitidis, Serogroup B - pathogenicity | Child | Neisseria meningitidis - pathogenicity | France - epidemiology | Genotype | Neisseria meningitidis - isolation & purification | Epidemics - statistics & numerical data | Vaccination - statistics & numerical data | Adolescent | Epidemics - prevention & control | Aged | Meningococcal Vaccines - administration & dosage | Meningitis | Vaccination | Genomics | Meningococcal Vaccines/administration & dosage | Neisseria meningitidis/genetics | France/epidemiology | Neisseria meningitidis, Serogroup B/genetics | Meningococcal Infections/mortality | Neisseria meningitidis, Serogroup B/pathogenicity | Life Sciences | Neisseria meningitidis/pathogenicity | Neisseria meningitidis/isolation & purification | Epidemics/statistics & numerical data | Meningococcal Infections/microbiology | Biochemistry, Molecular Biology | Human health and pathology | Vaccination/statistics & numerical data | Epidemics/prevention & control | Infectious diseases | Meningococcal Infections/epidemiology | Neisseria meningitidis, Serogroup B/isolation & purification | Santé publique et épidémiologie
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 04/2015, Volume 17, Issue 2, pp. 322 - 327
Immunization against meningococcal disease is recommended for solid organ transplant (SOT) recipients at high risk for meningococcal disease or travelling to... 
meningococcal vaccine | solid organ transplantation | Neisseria meningitidis | antibody response | immunization | Immunization | Solid organ transplantation | Antibody response | Meningococcal vaccine | IMMUNE-RESPONSE | INFECTIOUS DISEASES | CONJUGATE VACCINE | SAFETY | IMMUNOLOGY | CHILDREN | TRANSPLANTATION | RECOMMENDATIONS | REVACCINATION | ADOLESCENTS | DISEASE | C VACCINE | POLYSACCHARIDE | Immunocompromised Host - immunology | Neisseria meningitidis, Serogroup A - immunology | Liver Transplantation | Meningococcal Vaccines - therapeutic use | Neisseria meningitidis, Serogroup C - immunology | Prospective Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Transplant Recipients | Neisseria meningitidis - immunology | Vaccines, Conjugate - immunology | Adult | Female | Graft Rejection - prevention & control | Meningococcal Infections - prevention & control | Kidney Transplantation | Neisseria meningitidis, Serogroup Y - immunology | Neisseria meningitidis, Serogroup W-135 - immunology | Vaccines, Conjugate - therapeutic use | Antibodies, Bacterial - immunology | Aged | Meningococcal Vaccines - immunology | Cohort Studies | Transplantation of organs, tissues, etc | Organ transplant recipients | Meningitis | Vaccines | Immunosuppressive Agents | Antibodies, Bacterial | Life Sciences | Immunology | Neisseria meningitidis, Serogroup C | Vaccines, Conjugate | Neisseria meningitidis, Serogroup A | Meningococcal Vaccines | Neisseria meningitidis, Serogroup W-135 | Vaccinology | Neisseria meningitidis, Serogroup Y | Graft Rejection | Immunocompromised Host | Meningococcal Infections
Journal Article
PLoS Medicine, ISSN 1549-1277, 2006, Volume 3, Issue 9, pp. 1579 - 1586
Background Outbreaks of meningococcal meningitis ( meningitis caused by Neisseria meningitidis) are a major public health concern in the African "meningitis... 
AFRICA | MEDICINE, GENERAL & INTERNAL | ASSAY | NIGER | W135 | MENINGOCOCCAL MENINGITIS | SEQUENCE | IDENTIFICATION | CONFIDENCE | PCR | Neisseria meningitidis, Serogroup A - immunology | Predictive Value of Tests | Africa - epidemiology | Neisseria meningitidis, Serogroup C - immunology | Neisseria meningitidis, Serogroup W-135 - isolation & purification | Neisseria meningitidis, Serogroup Y - isolation & purification | Prospective Studies | Meningitis, Meningococcal - diagnosis | Humans | Meningitis, Meningococcal - epidemiology | Meningitis, Meningococcal - immunology | Polymerase Chain Reaction - methods | Likelihood Functions | Time Factors | Sensitivity and Specificity | Neisseria meningitidis, Serogroup C - isolation & purification | Serotyping | Reproducibility of Results | Chromatography - methods | Antibodies, Monoclonal | Neisseria meningitidis, Serogroup Y - immunology | Neisseria meningitidis, Serogroup A - isolation & purification | Neisseria meningitidis, Serogroup W-135 - immunology | Reagent Kits, Diagnostic | Meningitis, Meningococcal - cerebrospinal fluid | Evaluation Studies as Topic | Causes of | Medical tests | Neisseria meningitidis | Diagnosis | Health aspects | Bioengineering | Neisseria menin | Africa | Chromatography | Meningitis, Meningococcal | Neisseria meningitidis, Serogroup W-135 | Life Sciences | Human health and pathology | Infectious diseases | Immunology | Neisseria meningitidis, Serogroup C | Santé publique et épidémiologie | Neisseria meningitidis, Serogroup A | Evaluation Studies | Biotechnology | Public Health | Microbiology | Medicine in Developing Countries | Infectious Diseases | Vaccines | Primary Care | Epidemiology
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 02/2016, Volume 291, Issue 7, pp. 3224 - 3238
The degree of phosphorylation and phosphoethanolaminylation of lipid A on neisserial lipooligosaccharide (LOS), a major cell-surface antigen, can be correlated... 
infection | lipid A | phosphoethanolamine | ALKALINE-PHOSPHATASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | NORMAL HUMAN SERUM | SEROGROUP-B | Neisseria meningitidis | acylation | INNER-CORE | LACTO-N-NEOTETRAOSE | GRAM-NEGATIVE BACTERIA | FACTOR-H BINDING | sialic acid | LIPID-A | bioinformatics | ENDOTOXIN TOLERANCE | phosphorylation | MENINGOCOCCAL DISEASE | lipooligosaccharide | mass spectrometry (MS) | Meningococcal Infections - immunology | Tumor Necrosis Factor-alpha - metabolism | Carrier State - blood | Neisseria meningitidis, Serogroup C - immunology | Phosphorylation | Humans | Virulence | Neisseria meningitidis, Serogroup B - immunology | Carrier State - microbiology | Monocytes - metabolism | Gene Expression Profiling | Monocytes - immunology | Meningococcal Infections - microbiology | Neisseria meningitidis, Serogroup B - metabolism | Antigens, Bacterial - biosynthesis | Meningitis, Meningococcal - immunology | Neisseria meningitidis, Serogroup C - metabolism | Meningitis, Meningococcal - microbiology | Neisseria meningitidis, Serogroup C - classification | Carrier State - cerebrospinal fluid | Molecular Structure | Neisseria meningitidis, Serogroup B - pathogenicity | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Antigens, Bacterial - toxicity | Acylation | Carrier State - immunology | Sepsis - immunology | Antigens, Bacterial - chemistry | Lipopolysaccharides - toxicity | Immunity, Innate - drug effects | Computational Biology | Meningitis, Meningococcal - blood | Neisseria meningitidis, Serogroup C - pathogenicity | Monocytes - drug effects | Sepsis - cerebrospinal fluid | Meningococcal Infections - cerebrospinal fluid | Norway | Adolescent | Lipopolysaccharides - biosynthesis | Cell Line, Tumor | Meningitis, Meningococcal - cerebrospinal fluid | Neisseria meningitidis, Serogroup B - classification | Lipopolysaccharides - chemistry | Sepsis - blood | Meningococcal Infections - blood | Sepsis - microbiology | Microbiology
Journal Article
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 03/2006, Volume 44, Issue 3, pp. 1127 - 1131
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
CARRIED MENINGOCOCCI | POPULATION BIOLOGY | SURVEILLANCE | MICROBIOLOGY | DIVERSITY | CHAIN-REACTION PCR | MENINGOCOCCAL DISEASE | NONCULTURE DIAGNOSIS | EXPRESSION | NULL LOCUS | EPIDEMIOLOGY | Humans | Neisseria meningitidis, Serogroup A - classification | Carrier State - microbiology | Neisseria meningitidis, Serogroup Y - genetics | DNA Primers - genetics | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Neisseria meningitidis, Serogroup W-135 - pathogenicity | Serotyping - methods | Polymerase Chain Reaction - methods | Virulence - genetics | Neisseria meningitidis, Serogroup C - classification | Base Sequence | Neisseria meningitidis, Serogroup W-135 - classification | Sensitivity and Specificity | Neisseria meningitidis, Serogroup A - genetics | Neisseria meningitidis - genetics | Neisseria meningitidis, Serogroup B - pathogenicity | Neisseria meningitidis, Serogroup Y - classification | Polymerase Chain Reaction - statistics & numerical data | Serotyping - statistics & numerical data | Neisseria meningitidis - pathogenicity | Neisseria meningitidis, Serogroup C - genetics | Neisseria meningitidis, Serogroup W-135 - genetics | Neisseria meningitidis, Serogroup C - pathogenicity | DNA, Bacterial - genetics | Neisseria meningitidis - classification | Neisseria meningitidis, Serogroup A - pathogenicity | Neisseria meningitidis, Serogroup B - classification | Neisseria meningitidis, Serogroup Y - pathogenicity | Bacteriology
Journal Article
Journal of Infection, ISSN 0163-4453, 2008, Volume 57, Issue 4, pp. 324 - 331
Summary Objectives The aim of this study was to characterize Neisseria meningitidis strains causing invasive disease in Rio Grande do Sul (RS), during... 
Infectious Disease | Hypervirulent lineages | PorA VR types | Neisseria meningitidis | Epidemiology | Serogroup B vaccine | INFECTIOUS DISEASES | W135 MENINGOCOCCAL DISEASE | INVASIVE DISEASE | SEROGROUP-B | PORA TYPES | IDENTIFICATION | SEROSUBTYPES | VACCINE DESIGN | SURVEILLANCE | ZEALANDS EPIDEMIC | INFECTION | Meningococcal Infections - epidemiology | Neisseria meningitidis, Serogroup W-135 - isolation & purification | Prevalence | Humans | Child, Preschool | Infant | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Neisseria meningitidis, Serogroup B - isolation & purification | Meningitis, Meningococcal - epidemiology | Meningitis, Meningococcal - microbiology | Neisseria meningitidis, Serogroup C - classification | Bacterial Typing Techniques | Neisseria meningitidis, Serogroup W-135 - classification | Neisseria meningitidis - genetics | Neisseria meningitidis, Serogroup C - isolation & purification | Brazil - epidemiology | Serotyping | Neisseria meningitidis - pathogenicity | Neisseria meningitidis, Serogroup C - genetics | Neisseria meningitidis, Serogroup W-135 - genetics | Porins - genetics | Neisseria meningitidis - isolation & purification | Sequence Analysis, DNA | DNA, Bacterial - genetics | Neisseria meningitidis - classification | Molecular Epidemiology | Neisseria meningitidis, Serogroup B - classification | Population Surveillance | Prevalence studies (Epidemiology)
Journal Article
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 5/2009, Volume 199, Issue 9, pp. 1360 - 1368
Background. Meningococcal epidemics in Africa are generally caused by capsular group A strains, but W- 135 or X strains also cause epidemics in this region.... 
Epidemics | Antigens | Carrier proteins | Vaccination | Antibodies | Monoclonal antibodies | Amino acids | Bacteria | Neisseria meningitidis | Epidemiology | Meningococcal meningitis | INFECTIOUS DISEASES | IMMUNOGENICITY | NEW-ZEALAND | BACTERICIDAL ACTIVITY | BURKINA-FASO | MENINGITIDIS CANDIDATE VACCINE | NEISSERIA-MENINGITIDIS | SEROGROUP-B MENINGOCOCCUS | RANDOMIZED CONTROLLED-TRIAL | MONOCLONAL-ANTIBODIES | MEMBRANE VESICLE VACCINE | Neisseria meningitidis - pathogenicity | Complement Factor H - immunology | Africa - epidemiology | Neisseria meningitidis, Serogroup W-135 - isolation & purification | Neisseria meningitidis, Serogroup W-135 - genetics | Humans | Meningitis, Meningococcal - genetics | Complement System Proteins - immunology | Neisseria meningitidis - isolation & purification | Meningitis, Meningococcal - epidemiology | Meningitis, Meningococcal - immunology | Meningitis, Meningococcal - prevention & control | Neisseria meningitidis, Serogroup W-135 - pathogenicity | Epitopes - immunology | Neisseria meningitidis, Serogroup A - isolation & purification | Complement Factor H - metabolism | Neisseria meningitidis, Serogroup A - pathogenicity | Polymerase Chain Reaction | Neisseria meningitidis, Serogroup A - genetics | Antibodies, Bacterial - immunology | Bacterial Proteins - metabolism | Neisseria meningitidis - genetics | Epitopes - chemistry | Antigens, Bacterial - metabolism | Causes of | Physiological aspects | Genetic aspects | Research | Binding proteins | Gene expression | Meningococcal infections
Journal Article